Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/06/363   
Active ingredient: 4-[131I]iodo-L-phenylalanine
Indication: Treatment of glioma
Sponsor: Telix Pharmaceuticals Holdings Germany GmbH
Schweriner Str. 50a, 01067 Dresden, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/04/2006 Orphan designation EMEA/OD/110/05 (2006)1639 of 11/04/2006
7/02/2008 Transfer of orphan designation EMEA/OD/110/05/T/01 (2008)525 of 5/02/2008
27/07/2018 Transfer of orphan designation EMA/OD/110/05/T/02 (2018)5036 of 25/07/2018